8 September 2021 - Suboxone is among the medicines that will be withdrawn from the drug benefits at the companies' request on 1 October.
Suboxone 2 mg - 0.5 mg & 8 mg - 2 mg tablets will be withdrawn from the benefits at the request of the company.
Generic and parallel-distributed packaging remains within the benefits.